| __timestamp | MannKind Corporation | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100244000 | 2242216 |
| Thursday, January 1, 2015 | 29674000 | 4536244 |
| Friday, January 1, 2016 | 14917000 | 5184803 |
| Sunday, January 1, 2017 | 14118000 | 3068742 |
| Monday, January 1, 2018 | 8737000 | 7178000 |
| Tuesday, January 1, 2019 | 6900000 | 16267000 |
| Wednesday, January 1, 2020 | 6248000 | 23191000 |
| Friday, January 1, 2021 | 12312000 | 21453000 |
| Saturday, January 1, 2022 | 19721000 | 15265000 |
| Sunday, January 1, 2023 | 31283000 | 25189000 |
Cracking the code
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, MannKind Corporation and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to research and development (R&D) investment. MannKind, with its focus on inhalable insulin therapies, has consistently outpaced Soleno in R&D spending, peaking in 2014 with a staggering 100 million dollars. However, Soleno, specializing in rare disease treatments, has shown a steady increase in its R&D budget, culminating in a 25 million dollar investment in 2023. This represents a tenfold increase from its 2014 expenditure. While MannKind's R&D spending has fluctuated, Soleno's commitment to innovation has grown by approximately 1,000% over the same period. As these companies continue to navigate the challenges of the biotech industry, their investment strategies will undoubtedly shape their future trajectories.
Research and Development Investment: Johnson & Johnson vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and MannKind Corporation
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Soleno Therapeutics, Inc.
HUTCHMED (China) Limited vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How ImmunityBio, Inc. and MannKind Corporation Allocate Funds
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs MannKind Corporation